Circulating CD34-expressing cells: German Proficiency Testing Survey.
Determination of absolute numbers of CD34-expressing cells is critical in the setting of peripheral blood stem and progenitor cell transplantation/reinfusion. The diagnostic value of the parameter, CD34-expressing cells/microliter, has been validated. A survey of CD34-expressing cells has been integrated into a series of flow cytometry proficiency testing surveys (reticulocytes, lymphocytes, leukemia, and lymphoma) that we have established in Germany. Commercially available, modified, stabilized myeloblastic leukemia cells (KG1a cell line) spiked at different numbers into two normal blood samples were sent out, and report forms were returned from 50 of 58 participants. With a predicted percentage of CD34-expressing cells of 0.5% (sample A) and of 0.25% (sample B), the respective mean values analyzing data from 44 participants returning the completed forms were 0.49% (sample A) and 0.29% (sample B). The coefficients of variation were 57% and 83%, respectively. Engineered samples based on normal blood and on commercially available stabilized modified KG1a cells seem to be reliable material for external quality assessment surveys of CD34-expressing cells.
Serke
S
S
Department of Internal Medicine, Virchow-Klinikum, Humboldt-University, Berlin, Germany.
Huhn
D
D
D018952:Antigens, CD34 / Q000097:blood*; D019411:Clinical Laboratory Techniques / Q000592:standards*; D005434:Flow Cytometry / Q000592:standards; D005858:Germany; D019538:Health Care Surveys; D018380:Hematopoietic Stem Cell Transplantation / Q000592:standards*; D006412:Hematopoietic Stem Cells / Q000276:immunology*; D006801:Humans; D015203:Reproducibility of Results
D018952:Antigens, CD34